Investors / United States / HEDA Ventures
HEDA Ventures
Venture capital · Sunnyvale, CA, United States · North America
HEDA Ventures backs early-stage companies building breakthroughs in biotech, healthcare and TMT industries. It provides capital and strategic support to help entrepreneurs expand into global markets.
Invests inHealthcare & Biotech
In its own wordsbiotechhealthcaretherapeuticsdiagnosticstmt
Your fit with HEDA Ventures
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsHEDA Ventures lists 4 checked portfolio companies on its own site. Its largest theme is Healthcare & Biotech (100%). 50% of its companies are based in United States. It invests most often alongside Cloudstone Capital, HighLight Capital and StartX.
No funding round on record names HEDA Ventures yet, so the figures come from its portfolio page.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 100% | 15% |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| Cloudstone Capital | 1 |
| HighLight Capital | 1 |
| StartX | 1 |
| Viva BioInnovator | 1 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers4100%
- No longer answers00%
- Points to another company00%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Co-investor network
who it backs companies with, and who they back togetherAll co-investors or Compare portfolios with Cloudstone Capital
Compare HEDA Ventures head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Portfolio
4 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| Arthrosi Therapeutics is a clinical-stage biotech company focused on the development of therapy for gout and chronic kidney disease. | Healthcare & Biotech | Portfolio page | ||
| NeuCyte is a biotech company focused on generating quality iPSC-derived neural cells to develop treatments for neurological disorders. | Healthcare & Biotech | Portfolio page | ||
| Paragon Genomics develops and provides targeted library preparation kits and next-generation sequencing panels for various applications | Healthcare & Biotech | Portfolio page | ||
| The company develops medical devices using biopolymers, including a ventricular shunt for children with hydrocephalus. | Healthcare & Biotech | Portfolio page |
About this data
site last read 8 Nov 2026- Site
- hedaventures.com
- Last read
- 8 Nov 2026
- Watching since
- 6 Nov 2026
- Companies checked
- 4
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get HEDA Ventures' profile as data
Pull HEDA Ventures' portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/hedaventures.com
# also
GET /v1/firms/hedaventures.com/portfolio
GET /v1/firms/hedaventures.com/coinvestors
GET /v1/firms/hedaventures.com/news